Posaconazole to Treat Invasive Fungal Infections

NCT00033982 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Granulomatous Disease, Chronic
Job's Syndrome
Infection

Interventions

DRUG: Posaconazole

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)